• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜后 NF1 无关性恶性外周神经鞘瘤伴血清 CA125 升高:病例报告及讨论。

A retroperitoneal NF1-independent malignant peripheral nerve sheath tumor with elevated serum CA125: case report and discussion.

机构信息

Department of Traditional Chinese Medicine, Shanghai Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai, 200003, China.

出版信息

J Neurooncol. 2012 Aug;109(1):205-11. doi: 10.1007/s11060-012-0865-9. Epub 2012 Apr 19.

DOI:10.1007/s11060-012-0865-9
PMID:22528792
Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are usually located in the trunk, extremities, head, or neck, and most occur with neurofibromatosis type 1 (NF1; von Recklinghausen's disease). No biomarkers have previously been found to be associated with their progression. Retroperitoneal NF1-independent MPNSTs are rare; they are considered to be less aggressive and to have better prognoses compared to NF1-related tumors. Currently, en bloc excision is the only consensus treatment approach. In a 27-year-old male with a giant retroperitoneal MPNST and no stigmata or family history of neurofibromatosis type-1 (NF1), a remarkable elevation of serum CA125 was detected. The high-grade tumor displayed a striking progression: the primary lesion, 25 cm in diameter, recurred in its previous site as a 17-cm MPNST less than 50 days after total excision. Subsequent treatment with microwave ablation and huachansu, a traditional Chinese medication, proved ineffective, and the patient died within 3 months. Our case suggests that retroperitoneal MPNSTs can deteriorate rapidly even if NF1 independent, that aggressive treatment may not benefit large high-grade MPNSTs, and that novel and effective treatment is urgently needed. Our case also suggests the possibility of using serum tumor markers in the early detection and monitoring of MPNSTs.

摘要

恶性外周神经鞘瘤 (MPNST) 通常位于躯干、四肢、头部或颈部,大多数发生于神经纤维瘤病 1 型 (NF1;冯·雷克林豪森氏病)。以前没有发现与肿瘤进展相关的生物标志物。腹膜后 NF1 不相关的 MPNST 很少见;与 NF1 相关的肿瘤相比,它们被认为侵袭性较低,预后较好。目前,整块切除是唯一的共识治疗方法。在一名 27 岁的男性中,患有巨大的腹膜后 MPNST,没有 NF1(神经纤维瘤病 1 型)的体征或家族史,检测到血清 CA125 显著升高。高级别肿瘤表现出显著的进展:原发性病变,直径 25 厘米,在完全切除后不到 50 天就在其先前部位复发为 17 厘米的 MPNST。随后采用微波消融和华蟾素(一种中药)治疗,但无效,患者在 3 个月内死亡。我们的病例表明,即使是腹膜后 MPNST 也可能迅速恶化,即使 NF1 不相关,积极治疗可能对大型高级别 MPNST 无益,迫切需要新的有效治疗方法。我们的病例还表明,血清肿瘤标志物在 MPNST 的早期检测和监测中具有可能性。

相似文献

1
A retroperitoneal NF1-independent malignant peripheral nerve sheath tumor with elevated serum CA125: case report and discussion.腹膜后 NF1 无关性恶性外周神经鞘瘤伴血清 CA125 升高:病例报告及讨论。
J Neurooncol. 2012 Aug;109(1):205-11. doi: 10.1007/s11060-012-0865-9. Epub 2012 Apr 19.
2
[A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].[1例罕见的伴有横纹肌母细胞分化的神经鞘肉瘤(恶性蝾螈瘤)]
Tumori. 2003 Jul-Aug;89(4 Suppl):246-50.
3
Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.散发型、神经纤维瘤病 1 型相关和放射相关恶性外周神经鞘瘤的复发和生存模式。
J Neurosurg. 2017 Jan;126(1):319-329. doi: 10.3171/2015.12.JNS152443. Epub 2016 Apr 1.
4
Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.散发型、神经纤维瘤病相关和放疗诱导的恶性外周神经鞘瘤的肿瘤学结果。
Ann Surg Oncol. 2013 Jan;20(1):66-72. doi: 10.1245/s10434-012-2573-2. Epub 2012 Aug 10.
5
Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.临床基因组分析鉴定出1型神经纤维瘤病相关恶性外周神经鞘膜瘤患者中的酪氨酸激酶2(TYK2)突变和过表达。
Cancer. 2017 Apr 1;123(7):1194-1201. doi: 10.1002/cncr.30455. Epub 2016 Nov 22.
6
Intrathoracic malignant peripheral nerve sheath tumor in von Recklinghausen's disease.冯雷克林霍增氏病中的胸内恶性外周神经鞘瘤。
Korean J Intern Med. 2001 Sep;16(3):201-4. doi: 10.3904/kjim.2001.16.3.201.
7
[Retroperitoneal malignant peripheral nerve sheath tumor (MPNST) complicated with von Recklinghausen's disease: a case report].[腹膜后恶性外周神经鞘瘤(MPNST)合并冯雷克林霍增氏病:一例报告]
Hinyokika Kiyo. 2004 Jun;50(6):417-20.
8
Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors.神经纤维瘤病1型相关恶性外周神经鞘膜瘤突变图谱的确认
Genes Chromosomes Cancer. 2017 May;56(5):421-426. doi: 10.1002/gcc.22446. Epub 2017 Mar 7.
9
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.神经纤维瘤病 1 型的血清生物标志物和恶性外周神经鞘瘤的早期检测。
BMC Med. 2013 Apr 23;11:109. doi: 10.1186/1741-7015-11-109.
10
Malignant peripheral nerve sheath tumours associated with von Recklinghausen's neurofibromatosis.与冯雷克林霍增氏神经纤维瘤病相关的恶性外周神经鞘瘤。
Eur J Surg Oncol. 1999 Apr;25(2):190-3. doi: 10.1053/ejso.1998.0625.

引用本文的文献

1
The Multimodality Management of Malignant Peripheral Nerve Sheath Tumours.恶性外周神经鞘瘤的多模式管理
Cancers (Basel). 2024 Sep 26;16(19):3266. doi: 10.3390/cancers16193266.
2
Percutaneous Radiofrequency Ablation for the Treatment of Peripheral Nerve Sheath Tumors: A Case Report and Review of the Literature.经皮射频消融治疗周围神经鞘瘤:一例报告并文献复习
Cureus. 2018 Apr 25;10(4):e2534. doi: 10.7759/cureus.2534.

本文引用的文献

1
Direct reprogramming of stem cell properties in colon cancer cells by CD44.CD44 直接重编程结肠癌干细胞特性。
EMBO J. 2011 Jun 24;30(15):3186-99. doi: 10.1038/emboj.2011.211.
2
Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial-mesenchymal transition.辐射通过 TMPRSS4 诱导的上皮-间充质转化增强裸鼠残余肝细胞癌的长期转移潜能。
Cancer Gene Ther. 2011 Sep;18(9):617-26. doi: 10.1038/cgt.2011.29. Epub 2011 Jun 3.
3
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
他莫昔芬通过雌激素受体非依赖途径抑制恶性外周神经鞘瘤的生长。
Neuro Oncol. 2011 Jan;13(1):28-41. doi: 10.1093/neuonc/noq146. Epub 2010 Nov 12.
4
Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.草药复方“松友饮”增强了干扰素-α抑制裸鼠肝癌姑息性切除后增强转移潜能的能力。
BMC Cancer. 2010 Oct 25;10:580. doi: 10.1186/1471-2407-10-580.
5
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.一线化疗治疗恶性外周神经鞘瘤(MPNST)与其他组织学软组织肉瘤亚型以及作为 MPNST 的预后因素:EORTC 软组织和骨肉瘤组研究。
Ann Oncol. 2011 Jan;22(1):207-214. doi: 10.1093/annonc/mdq338. Epub 2010 Jul 23.
6
Is there really a yin and yang to VEGF-targeted therapies?VEGF靶向治疗真的存在阴阳两面吗?
Lancet Oncol. 2010 Sep;11(9):809-11. doi: 10.1016/S1470-2045(10)70161-3. Epub 2010 Jul 13.
7
Molecularly targeted therapy: when to stop and when to continue?分子靶向治疗:何时停止,何时继续?
Lancet Oncol. 2010 Aug;11(8):709-11. doi: 10.1016/S1470-2045(10)70128-5.
8
The early detection of recurrence of malignant peripheral nerve sheath tumor by frequent magnetic resonance imaging.通过频繁的磁共振成像早期检测恶性外周神经鞘瘤的复发
J Korean Neurosurg Soc. 2010 Jan;47(1):51-4. doi: 10.3340/jkns.2010.47.1.51. Epub 2010 Jan 31.
9
Breast cancer stem cells: eradication by differentiation therapy?乳腺癌干细胞:通过分化疗法根除?
Cell. 2009 Aug 21;138(4):623-5. doi: 10.1016/j.cell.2009.08.007.
10
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer.华蟾素用于肝细胞癌、非小细胞肺癌或胰腺癌患者的初步研究。
Cancer. 2009 Nov 15;115(22):5309-18. doi: 10.1002/cncr.24602.